PlainRecalls
FDA Devices Moderate Class II Ongoing

Advia Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP), SMN 11319151

Reported: November 3, 2021 Initiated: September 20, 2021 #Z-0181-2022

Product Description

Advia Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP), SMN 11319151

Reason for Recall

The firm has confirmed the potential for ADVIA Chemistry Urinary/Cerebrospinal Fluid Protein reagent carryover impacting Enzymatic Hemoglobin A1c (A1c_E and A1c_EM) results. Falsely depressed Enzymatic Hemoglobin A1c results may affect consideration of intervention.

Details

Units Affected
246 (US); 689 (OUS)
Distribution
Worldwide distribution - US Nationwide distribution.
Location
Tarrytown, NY

Frequently Asked Questions

What product was recalled?
Advia Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP), SMN 11319151. Recalled by Siemens Healthcare Diagnostics, Inc.. Units affected: 246 (US); 689 (OUS).
Why was this product recalled?
The firm has confirmed the potential for ADVIA Chemistry Urinary/Cerebrospinal Fluid Protein reagent carryover impacting Enzymatic Hemoglobin A1c (A1c_E and A1c_EM) results. Falsely depressed Enzymatic Hemoglobin A1c results may affect consideration of intervention.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 3, 2021. Severity: Moderate. Recall number: Z-0181-2022.